blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1692181

EP1692181 - LEPTIN ANTAGONIST AND METHOD FOR QUANTITATIVE MEASUREMENT OF LEPTIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.11.2012
Database last updated on 02.11.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Biofusion Licensing (Sheffield) Limited
The Sheffield Bioincubator
40 Leavygreave Road
Sheffield
S3 7RD / GB
[2012/46]
Former [2012/02]For all designated states
Klinikum der Universität München
Grosshadern-Innenstadt, Lindwurmstrasse 2a
80337 München / DE
For all designated states
University of Sheffield
Western Bank
Sheffield, S10 2TN / GB
Former [2006/34]For all designated states
Klinikum der Universität München
Grosshadern-Innenstadt, Lindwurmstrasse 2a
80337 München / DE
For all designated states
University of Sheffield
Western Bank
Sheffield, S10 2TN / GB
Inventor(s)01 / STRASBURGER, Christian, J.
Marchwartweg 8
85635 Höhenkirchen / DE
02 / BIDLINGMAIER, Martin
Schleissheimerstr. 68
80797 München / DE
03 / WU, Zida
Strassbergerstr. 10
80809 München / DE
04 / ROSS, Richard, J., M.
96 Union Rd
Sheffield S11 9EJ / GB
05 / MATARESE, Giuseppe@Inst. di Éndocrinol. e Oncolog.
Sperimen.
Consiglio Naz. delle Ricerche (IEOS-NCR)
Napoli / IT
 [2012/02]
Former [2006/34]01 / STRASBURGER, Christian, J.
Marchwartweg 8
85635 Höhenkirchen / DE
02 / BIDLINGMAIER, Martin
Schleissheimerstr. 68
80797 München / DE
03 / WU, Zida
Strassbergerstr. 10
80809 München / DE
04 / ROSS, Richard, J., M.
96 Union Rd
Sheffield S11 9EJ / GB
05 / MATARESE, Giuseppe Inst. di Éndocrinol. e Oncolog.
Sperimen. Consiglio Naz. delle Ricerche (IEOS-NCR)
Napoli / IT
Representative(s)Docherty, Robert Charles
Symbiosis IP Limited
York Biotech Campus
Office 14FA05
Sand Hutton
York, YO41 1LZ / GB
[N/P]
Former [2012/02]Docherty, Robert Charles
Symbiosis IP Limited Apollo House Eboracum Way
Heworth Green, York YO31 7RE / GB
Former [2011/16]Docherty, Robert Charles
Symbiosis IP Limited Apollo House Eboracum Way
Heworth Green, York YO31 7RE / GB
Former [2007/07]Gilholm Harrison Ltd
Marlborough House Westminster Place York Business Park
Nether Poppleton, York YO26 6RW / GB
Former [2006/49]Harrison Goddard Foote
31 St Saviourgate
York Y01 8NQ / GB
Former [2006/34]Docherty, Robert Charles
Harrison Goddard Foote 31 St. Saviourgate
York YO1 8NQ / GB
Application number, filing date04797956.217.11.2004
[2006/34]
WO2004EP13043
Priority number, dateDE2003105359317.11.2003         Original published format: DE 10353593
[2006/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005049655
Date:02.06.2005
Language:EN
[2005/22]
Type: A1 Application with search report 
No.:EP1692181
Date:23.08.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 02.06.2005 takes the place of the publication of the European patent application.
[2006/34]
Type: B1 Patent specification 
No.:EP1692181
Date:11.01.2012
Language:EN
[2012/02]
Search report(s)International search report - published on:EP02.06.2005
ClassificationIPC:C07K16/28, G01N33/74, G01N33/53
[2006/34]
CPC:
C07K16/2869 (EP,US); A61P1/04 (EP); A61P1/14 (EP);
A61P1/16 (EP); A61P17/00 (EP); A61P17/06 (EP);
A61P17/14 (EP); A61P19/02 (EP); A61P21/00 (EP);
A61P21/04 (EP); A61P25/00 (EP); A61P29/00 (EP);
A61P3/00 (EP); A61P3/04 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P37/02 (EP); A61P37/06 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P5/14 (EP);
A61P7/00 (EP); A61P9/04 (EP); G01N33/74 (EP,US);
C07K2317/55 (EP,US); C07K2317/56 (EP,US); C07K2317/74 (EP,US);
C07K2317/75 (EP,US); C07K2317/76 (EP,US); G01N2333/575 (EP,US);
G01N2333/715 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/34]
TitleGerman:LEPTINANTAGONIST UND VERFAHREN ZUR QUANTITATIVEN MESSUNG VON LEPTIN[2006/34]
English:LEPTIN ANTAGONIST AND METHOD FOR QUANTITATIVE MEASUREMENT OF LEPTIN[2006/34]
French:ANTAGONISTE DE LEPTINE ET PROCEDE DE MESURE QUANTITATIVE DE LEPTINE[2006/34]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase30.05.2006National basic fee paid 
30.05.2006Designation fee(s) paid 
30.05.2006Examination fee paid 
Examination procedure30.05.2006Examination requested  [2006/34]
14.12.2006Despatch of a communication from the examining division (Time limit: M06)
03.09.2007Reply to a communication from the examining division
30.06.2009Despatch of a communication from the examining division (Time limit: M06)
16.02.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
19.04.2010Reply to a communication from the examining division
23.05.2011Cancellation of oral proceeding that was planned for 27.05.2011
27.05.2011Date of oral proceedings (cancelled)
29.06.2011Communication of intention to grant the patent
26.10.2011Fee for grant paid
26.10.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.12.2006
Opposition(s)12.10.2012No opposition filed within time limit [2012/51]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
19.04.2010Request for further processing filed
19.04.2010Full payment received (date of receipt of payment)
03.09.2007Request for further processing filed
03.09.2007Full payment received (date of receipt of payment)
Request granted
26.09.2007Decision despatched
Fees paidRenewal fee
28.11.2006Renewal fee patent year 03
22.11.2007Renewal fee patent year 04
20.05.2009Renewal fee patent year 05
12.05.2010Renewal fee patent year 06
03.11.2010Renewal fee patent year 07
28.11.2011Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
30.11.200805   M06   Fee paid on   20.05.2009
30.11.200906   M06   Fee paid on   12.05.2010
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU17.11.2004
AT11.01.2012
BE11.01.2012
CY11.01.2012
CZ11.01.2012
EE11.01.2012
FI11.01.2012
PL11.01.2012
RO11.01.2012
SI11.01.2012
SK11.01.2012
TR11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
[2014/34]
Former [2014/21]AT11.01.2012
BE11.01.2012
CY11.01.2012
CZ11.01.2012
EE11.01.2012
FI11.01.2012
PL11.01.2012
RO11.01.2012
SI11.01.2012
SK11.01.2012
TR11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
Former [2013/07]AT11.01.2012
BE11.01.2012
CY11.01.2012
CZ11.01.2012
EE11.01.2012
FI11.01.2012
PL11.01.2012
RO11.01.2012
SI11.01.2012
SK11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
Former [2012/50]BE11.01.2012
CY11.01.2012
CZ11.01.2012
EE11.01.2012
FI11.01.2012
PL11.01.2012
RO11.01.2012
SI11.01.2012
SK11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
Former [2012/49]BE11.01.2012
CY11.01.2012
CZ11.01.2012
EE11.01.2012
FI11.01.2012
PL11.01.2012
RO11.01.2012
SI11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
Former [2012/48]BE11.01.2012
CY11.01.2012
EE11.01.2012
FI11.01.2012
PL11.01.2012
SI11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
Former [2012/41]BE11.01.2012
CY11.01.2012
FI11.01.2012
PL11.01.2012
SI11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
Former [2012/37]BE11.01.2012
FI11.01.2012
PL11.01.2012
SI11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
Former [2012/36]BE11.01.2012
SI11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
Former [2012/35]BE11.01.2012
SI11.01.2012
BG11.04.2012
IS11.05.2012
Former [2012/34]BE11.01.2012
SI11.01.2012
IS11.05.2012
Former [2012/33]BE11.01.2012
SI11.01.2012
Former [2012/25]SI11.01.2012
Cited inInternational search[X]WO9959614  (UNIV YALE [US], et al) [X] 1-21,33-35,40-42 * page 24, line 12 - line 18 * * example 1 *;
 [X]WO0076552  (BAYLOR COLLEGE MEDICINE [US]) [X] 1-21,33-35,40-42* page 27, line 6 - line 7 *;
 [X]  - WU ZIDA ET AL, "Quantification of the soluble leptin receptor in human blood by ligand-mediated immunofunctional assay", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, (200206), vol. 87, no. 6, ISSN 0021-972X, pages 2931 - 2939, XP002323286 [X] 1-21,33-35,40-42 * abstract * * page 2932, column R, paragraph 2 - page 2933, column R, paragraph L * * figure 2 *
 [X]  - MAINGRETTE FRITZ ET AL, "Leptin increases lipoprotein lipase secretion by macrophages: Involvement of oxidative stress and protein kinase C.", DIABETES, (200308), vol. 52, no. 8, ISSN 0012-1797, pages 2121 - 2128, XP002323287 [X] 1-21,33-35,40-42 * abstract * * page 2121, column R, paragraph L - page 2122, column L, paragraph 1 * * page 2123, column R, paragraph 3 * * figure 3 *

DOI:   http://dx.doi.org/10.2337/diabetes.52.8.2121
 [X]  - CORSONELLO A ET AL, "Leptin-dependent platelet aggregation in healthy, overweight and obese subjects.", INTERNATIONAL JOURNAL OF OBESITY, (200305), vol. 27, no. 5, ISSN 0307-0565, pages 566 - 573, XP002323288 [X] 1-21,33-35,40-42 * abstract * * page 567, column R, paragraph 5 * * page 569, column L, paragraph 2 * * figure 4 *

DOI:   http://dx.doi.org/10.1038/sj.ijo.0802273
 [X]  - IVERSEN PER OLE ET AL, "Prevention of leptin binding to its receptor suppresses rat leukemic cell growth by inhibiting angiogenesis.", BLOOD, (20021201), vol. 100, no. 12, ISSN 0006-4971, pages 4123 - 4128, XP002323289 [X] 1-21,33-35,40-42 * abstract * * page 4124, column L, paragraph 3 * * figure 2 *

DOI:   http://dx.doi.org/10.1182/blood-2001-11-0134
Examination   - BERGTOLD F, "Circuits; integrated, combined and connected", INSPEC, THE INSTITUTION OF ELECTRICAL ENGINEERS, STEVENAGE, GB, (196809), Database accession no. 2114
    - AUTOMATIK WEST GERMANY, vol. 13, no. 9, ISSN 0005-1136, pages 301 - 303
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.